← MHRA ALERTS
MHRA (UK) · DRUG SAFETY UPDATE5 February 2026

Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Alert type
Drug Safety Update
Alert date
5 February 2026
Regulator
MHRA (United Kingdom)
READ THE FULL ALERT

The complete MHRA alert — the affected products, batches, and the action required — is published on GOV.UK. SPEQ surfaces and indexes it for reference; the authoritative notice lives on gov.uk.

View on gov.uk →
TURN IT INTO ACTION
About the MHRAThe UK regulator and the standards it enforces →Assess your quality systemBaseline against 12 GxP domains in 10 minutes →All MHRA alertsBrowse the live UK alert feed →

Alert details are published by the UK MHRA on GOV.UK; SPEQ surfaces them for reference and is not affiliated with or endorsed by the MHRA. The authoritative notice is on gov.uk.